[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586573":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":29,"centralContacts":33,"locations":39,"responsibleParty":57,"collaborators":25,"id":59,"slug":25,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":62,"acronym":25,"eligibilityCriteria":63,"healthyVolunteers":60,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":25,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":78,"overallStatus":42,"whyStopped":25,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Universidade Federal Fluminense","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Royal Jelly Group","EXPERIMENTAL","Participants will receive 2 capsules per day, providing the dosage of 300mg of royal jelly for 2 months (8 weeks).",[13],"Dietary Supplement: Royal Jelly",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo Group","PLACEBO_COMPARATOR","The placebo group will receive 2 capsules per day (containing microcrystalline cellulose and magnesium stearate in colored gelatin capsules capable of masking the appearance of the internal content), at the same time for 2 months.",[19],"Dietary Supplement: Placebo",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","Royal Jelly",[9],null,{"type":22,"name":27,"description":17,"armGroupLabels":28,"otherNames":25},"Placebo",[15],[30],{"name":31,"affiliation":5,"role":32},"Ludmila Cardozo, PhD","PRINCIPAL_INVESTIGATOR",[34],{"name":35,"role":36,"phone":37,"phoneExt":25,"email":38},"Denise mafra, PhD","CONTACT","+5521985683003","dmafra30@gmail.com",[40],{"facility":41,"status":42,"city":43,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Denise Mafra","RECRUITING","Rio de Janeiro","22260050","Brazil","BR",{"type":48,"coordinates":49},"Point",[50,51],-43.18223,-22.90642,{"lat":51,"lon":50},[54],{"name":31,"role":36,"phone":55,"phoneExt":25,"email":56},"+5521987333185","ludmila.cardozo@gmail.com",{"type":58,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100586573",false,"NCT06917131","Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension","Inclusion Criteria:\n\n* Diagnosis of stage 1 hypertension\n* Regular treatment for more than 6 months\n* No changes in medication doses during the last 3 months\n\nExclusion Criteria:\n\n* Autoimmune diseases\n* Infectious diseases\n* Diabetes\n* Chronic kidney disease\n* Liver disease\n* Cancer\n* AIDS\n* Pregnant women\n* Use of catabolic drugs or antibiotics\n* Use of antioxidant vitamin supplements, prebiotics, probiotics, or synbiotics\n* Habitual intake of royal jelly\n* Allergy to bee stings\n* Acute myocardial infarction (AMI)\n* Stroke (CVA)","ALL","18 Years","75 Years",{"count":68,"type":69},34,"ESTIMATED","INTERVENTIONAL",[72],"NA","The study aims to evaluate the effect of the royal jelly on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.",[75,76,77],"Hypertension","Cardiovascular Diseases (CVD)","Inflammation",[79,80,75,81],"royal jelly","inflammation","cardiovascular diseases","2026-05-14",{"date":84,"type":85},"2026-05-19","ACTUAL",{"date":87,"type":85},"2024-09-18",{"date":89,"type":69},"2026-12-10",{"name":5,"class":6},1]